4-((3R,5S)-4-acryloyl-3,5-dimethylpiperazin-1-yl)-7-(2-amino-3,5-dichloro-6-fluorophenyl)-6-chloro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carbonitrile

ID: ALA4873282

PubChem CID: 156785271

Max Phase: Preclinical

Molecular Formula: C33H31Cl3FN7O2

Molecular Weight: 683.01

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)N1[C@H](C)CN(c2c(C#N)c(=O)n(-c3c(C)ccnc3C(C)C)c3nc(-c4c(N)c(Cl)cc(Cl)c4F)c(Cl)cc23)C[C@@H]1C

Standard InChI:  InChI=1S/C33H31Cl3FN7O2/c1-7-24(45)43-17(5)13-42(14-18(43)6)31-19-10-23(36)29(25-26(37)21(34)11-22(35)27(25)39)41-32(19)44(33(46)20(31)12-38)30-16(4)8-9-40-28(30)15(2)3/h7-11,15,17-18H,1,13-14,39H2,2-6H3/t17-,18+

Standard InChI Key:  WRUSEXGILYGCCV-HDICACEKSA-N

Molfile:  

 
     RDKit          2D

 46 50  0  0  0  0  0  0  0  0999 V2000
   16.2445   -8.9435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2433   -9.7709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9582  -10.1838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6745   -9.7705    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6717   -8.9399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9563   -8.5308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6777   -7.0624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6765   -7.8899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3913   -8.3027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1078   -7.8894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1050   -7.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3896   -6.6497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9631   -6.6501    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   13.3911   -9.1277    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   14.8230   -8.3007    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.3871   -5.8247    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8178   -6.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5311   -7.0565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5199   -5.4065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8103   -5.8233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0924   -5.4169    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   16.2409   -5.8160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2415   -6.6416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9527   -7.0516    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6680   -6.6406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6674   -5.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9516   -5.4005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3821   -7.0536    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5299   -8.5312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3847   -8.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1006   -8.9345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3815   -7.6998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3777   -5.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0923   -4.9894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9498   -4.5755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6709   -4.1646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6712   -3.3432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9577   -2.9284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2422   -3.3411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2403   -4.1687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3864   -2.9319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9591   -2.1034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6742   -1.6921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2453   -1.6897    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6757   -0.8671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5283   -2.9277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  7 13  1  0
  9 14  1  0
 10 15  1  0
 12 16  1  0
 11 17  1  0
 17 18  2  0
 18 23  1  0
 22 19  1  0
 19 20  2  0
 20 17  1  0
 20 21  1  0
 22 23  2  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 25 28  2  0
 24  6  1  0
  1 29  1  0
  5 30  1  0
 30 31  1  0
 30 32  1  0
 33 34  3  0
 26 33  1  0
 27 35  1  0
 35 36  1  0
 35 40  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 37 41  1  6
 38 42  1  0
 42 43  1  0
 42 44  2  0
 43 45  2  0
 39 46  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4873282

    ---

Associated Targets(Human)

KRAS Tclin GTPase KRas (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H358 (882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 683.01Molecular Weight (Monoisotopic): 681.1589AlogP: 7.04#Rotatable Bonds: 5
Polar Surface Area: 121.14Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 5.54CX LogP: 6.23CX LogD: 6.22
Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.14Np Likeness Score: -0.65

References

1. Kargbo RB..  (2021)  Targeting KRAS Mutant Protein Inhibitor for Potential Treatment in Cancer.,  12  (11.0): [PMID:34795848] [10.1021/acsmedchemlett.1c00496]

Source